Creating and capturing value in the biopharmaceutical sector

摘要: This study addresses the ongoing implications of realignment pharmaceutical industry knowledge base – from small molecule methods to new biomedical technologies for competitive positions traditional pharmaceutical companies and biopharmaceutical start-ups. The theoretical approach draws on modern theory firm related concepts, define develop concept business model. is employed guide empirical analysis, which utilises a combination data analyses case studies based several sources, including detailed company reports alliance databases. thesis how companies have successfully adjusted their models meet challenge biotechnology so retain powerful position in industry. Central this has been breadth depth transfer through formation. Not only critical adjustment process the large but also development many start ups. Nonetheless these smaller weaknesses, led erosion value of their initial strategic assets. Despite poor financial performance vast majority firms, sector as whole created significant value. captured disproportionately by handful large fully integrated firms and, lesser extent, largest dozen firms.